300497 Jiangxi Fushine Pharmaceutical

Watchlist

Market Closed Mar 31 15:00 CST

4.64BMarket Cap-25.55P/E (TTM)

Jiangxi Fushine Pharmaceutical Key Stats

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Jul 30, 2019	2019/Q2	297.157M / 349.000M	--
Apr 29, 2019	2019/Q1	295.203M / 330.000M	--

DatePeriodRevenue/EstimateEarnings Call

Jul 30, 20192019/Q2297.157M / 349.000M--

Apr 29, 20192019/Q1295.203M / 330.000M--

--------

Unlock Free Earnings Estimates

Open Account

Fuxiang Pharmaceutical: 2024 Annual Results Forecast

Jan 24 06:36 ET

Fuxiang Pharmaceutical: Report for the third quarter of 2024

Oct 23, 2024 12:00 ET

Fuxiang Pharmaceutical: 2024 Semi-Annual Report Summary

Aug 28, 2024 12:00 ET

Fuxiang Pharmaceutical: 2024 Semi-Annual Report

Aug 28, 2024 12:00 ET